Crispant analysis in zebrafish as a tool for rapid functional screening of disease-causing genes for bone fragility
eLife · 16.01.2025 · 13
DOI: 10.7554/elife.100060 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 16.01.2025. Verfasst von Sophie Debaenst und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Medical Genetics Ghent, Department of Biomolecular Medicine, Ghent University, Ghent, Belgium. Hauptthemen laut MEDLINE: Zebrafish, Osteogenesis Imperfecta. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, Fonds Wetenschappelijk Onderzoek.
Abstract (Originalsprache)
Heritable fragile bone disorders (FBDs), ranging from multifactorial to rare monogenic conditions, are characterized by an elevated fracture risk. Validating causative genes and understanding their mechanisms remain challenging. We assessed a semi-high throughput zebrafish screening platform for rapid in vivo functional testing of candidate FBD genes. Six genes linked to severe recessive osteogenesis imperfecta (OI) and four associated with bone mineral density (BMD) from genome-wide association studies were analyzed using CRISPR/Cas9-based crispant screening in F0 mosaic founder zebrafish. Next-generation sequencing confirmed high indel efficiency (mean 88%), mimicking stable knock-out models. Skeletal phenotyping at 7, 14, and 90 days post-fertilization (dpf) using microscopy, Alizarin Red S staining, and microCT was performed. Larval crispants showed variable osteoblast and mineralization phenotypes, while adult crispants displayed consistent skeletal defects, including malformed neural and haemal arches, vertebral fractures and fusions, and altered bone volume and density. In addition, aldh7a1 and mbtps2 crispants experienced increased mortality due to severe skeletal deformities. RT-qPCR revealed differential expression of osteogenic markers bglap and col1a1a , highlighting their biomarker potential. Our results establish zebrafish crispant screening as a robust tool for FBD gene validation, combining skeletal and molecular analyses across developmental stages to uncover novel insights into gene functions in bone biology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Medical Genetics Ghent, Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
- Center for X-ray Tomography, Department of Physics and Astronomy, Ghent University, Ghent, Belgium.
- Department of Orthopaedics and Sports Medicine, University of Washington, Seattle, United States.
- Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, United States.
ORCID-Profile: Sophie Debaenst, Ronald Y Kwon, Andy Willaert
Förderung
- NIAMS NIH HHS
- Fonds Wetenschappelijk Onderzoek
Zitieren
APA
Debaenst, S., Jarayseh, T., De Saffel, H., Bek, J. W., Boone, M., Josipovic, I., Kibleur, P., Kwon, R. Y., Coucke, P. J., & Willaert, A. (2025). Crispant analysis in zebrafish as a tool for rapid functional screening of disease-causing genes for bone fragility. eLife, 13. https://doi.org/10.7554/elife.100060
Vancouver
Debaenst S, Jarayseh T, De Saffel H, Bek JW, Boone M, Josipovic I, et al. Crispant analysis in zebrafish as a tool for rapid functional screening of disease-causing genes for bone fragility. eLife. 2025;13. doi:10.7554/elife.100060
BibTeX
@article{Debaenst2025,
author = {Debaenst, Sophie and Jarayseh, Tamara and De Saffel, Hanna and Bek, Jan Willem and Boone, Matthieu and Josipovic, Ivan and Kibleur, Pierre and Kwon, Ronald Y and Coucke, Paul J and Willaert, Andy},
title = {Crispant analysis in zebrafish as a tool for rapid functional screening of disease-causing genes for bone fragility},
journal = {eLife},
year = {2025},
volume = {13},
doi = {10.7554/elife.100060}
}
EUVIMED